


The objective is to achieve capital growth on a medium to long-term basis.
| Name | % Net Assets |
|---|---|
| CF Walker Crips UK High Alpha Acc | 8.5% |
| Close Enhanced Commodities | 7.5% |
| Allian z RCM BRIC Stars C Acc | 7.0% |
| AXA Framlington UK Growth Acc | 5.5% |
| Schroders Strategic Bond A Inc | 5.3% |
| AXA Framlington Biotech Fu nd Acc | 4.8% |
| GlaxoSmithKline | 4.7% |
| BP | 4.4% |
| Barcap S&P Note 2 4/11/2009 6% | 3.8% |
| BG Group | 3.3% |
| Key | % Net Assets |
|---|---|
| 8.5% | |
| 7.5% | |
| 7.0% | |
| 5.5% | |
| 71.5% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | n/a |
|---|---|
| Fund Manager | n/a |
| TER | 2.28 (30-Nov-2011) |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | 500 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.45% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research